Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Standard Bupivacaine for Postoperative Pain After Eye Removal
NCT02381353Phase 4Active, not recruiting
- Sponsor
- Mayo Clinic
- Start
- Feb 2015
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Mayo Clinic. Primary endpoint: Postoperative orbital pain at Day 3. Started Feb 2015; status: active, not recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02381353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02381353.